Literature DB >> 32475825

Unusual presentation of idiopathic intracranial hypertension.

Ayman Alboudi1,2, Emily C Johnson3.   

Abstract

Idiopathic intracranial hypertension typically presents with holocephalic headache associated with nausea, vomiting and bilateral papilledema. Involvement of the sixth cranial nerve is relatively common. The involvement of other cranial nerves, however, is rare in this disorder. We describe a patient with idiopathic intracranial hypertension who presented with episodic unilateral retro-orbital pain and multiple cranial nerve abnormalities without papilledema. Imaging studies excluded alternate diagnoses, and the immediate resolution of symptoms after lumbar puncture confirmed that these symptoms were due to intracranial hypertension. Atypical presentations of such a disabling yet treatable disorder is very important to recognise and address. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  headache (including migraines); neuroimaging; neurology

Mesh:

Substances:

Year:  2020        PMID: 32475825      PMCID: PMC7264635          DOI: 10.1136/bcr-2020-234741

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Visual outcome in a prospective study of idiopathic intracranial hypertension.

Authors:  F J Rowe; N J Sarkies
Journal:  Arch Ophthalmol       Date:  1999-11

2.  Electrophysiological evidence of trigeminal neuropathy in pseudotumor cerebri.

Authors:  Ethem Murat Arsava; K Uluc; G Nurlu; T Kansu
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

3.  The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Authors:  Michael Wall; Mark J Kupersmith; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Michael P McDermott
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

Review 4.  Medication-induced intracranial hypertension in dermatology.

Authors:  Deborah I Friedman
Journal:  Am J Clin Dermatol       Date:  2005       Impact factor: 7.403

5.  Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy.

Authors:  I Francois; I Casteels; J Silberstein; P Casaer; F de Zegher
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

6.  The headache profile of idiopathic intracranial hypertension.

Authors:  M Wall
Journal:  Cephalalgia       Date:  1990-12       Impact factor: 6.292

7.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

8.  Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990.

Authors:  K Radhakrishnan; J E Ahlskog; S A Cross; L T Kurland; W M O'Fallon
Journal:  Arch Neurol       Date:  1993-01

9.  Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center.

Authors:  S J Wang; S D Silberstein; S Patterson; W B Young
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

10.  All choked up about the pseudotumor cerebri syndrome.

Authors:  Steven L Galetta; Laura J Balcer
Journal:  Neurology       Date:  2013-08-14       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.